Saudi King Salman to Undergo Treatment for Lung Inflammation
Saudi King Salman is receiving treatment for lung inflammation, leading to the postponement of Crown Prince Mohammed Bin Salman's visit to Japan. The King's health is being closely monitored, and the Crown Prince is handling regional developments. Header Tags:
Saudi King Salman to Undergo Treatment for Lung Inflammation
Saudi Arabia's King Salman will undergo treatment for lung inflammation at Al Salam Palace in Jeddah, according to recent reports. The 88-year-old monarch will receive antibiotic treatment until the inflammation subsides, as confirmed by the state news agency quoting the royal court.
Impact on Crown Prince's Visit to Japan
The King's health condition has led to the postponement of Crown Prince Mohammed Bin Salman's visit to Japan, which was scheduled to begin on Monday. Japan's Chief Cabinet Secretary, Yoshimasa Hayashi, confirmed the news, citing the King's health as the reason for the postponement.
Previous Hospitalization
In April, King Salman was previously hospitalized for a routine check-up, indicating that the monarch's health is being closely monitored by medical professionals.
Crown Prince's Role
As the de facto leader of Saudi Arabia, Crown Prince Mohammed Bin Salman has been handling regional developments in his father's place. During a recent meeting with US National Security Adviser Jake Sullivan, the Crown Prince discussed pressing regional issues, including the ongoing conflict in Gaza and the need to stop the war.
King Salman's Health
King Salman has been king of Saudi Arabia since the death of King Abdullah in 2015. In 2020, he underwent surgery to remove his gallbladder, highlighting the monarch's ongoing health concerns.
In summary, Saudi King Salman is undergoing treatment for lung inflammation, which has led to the postponement of Crown Prince Mohammed Bin Salman's visit to Japan. The King's health is being closely monitored, and the Crown Prince is handling regional developments in his place.
What's Your Reaction?
